Tag Archives: BC Centre for Disease Control

New Viral Load Testing and Genotyping Recommendations

Viral Load Testing and Genotyping RecommendationsThe BC Centre for Disease Control’s New Viral Load Testing and Genotyping Recommendations

The BC Centre for Disease Control (BCCDC) has published new viral load testing recommendations for those taking one of the following hep C treatments:

BCCDC Recommends Viral Load Tests be Done:
  • No more than 6 months before starting treatment
  • Right after treatment
  • 12 weeks after treatment
  • 24 weeks after treatment
BCCDC Viral Load Testing Recommendations for those taking Pegylated Interferon and Ribavirin are:
  • No more than 6 months before starting treatment
  • Week 4 of treatment for those with hep C genotype 2
  • Week 4 and 12 of treatment for those with hep C genotype 3
  • Week 12 after treatment to confirm a cure
  • Week 24 after treatment to confirm a cure
BCCDC Hep C Genotyping Recommendations
  • Prior genotyping results for those with genotypes 2 – 6 should be considered valid
  • Patients with genotype 1 hep C should be retested before treatment. This is because genotyping done before May 2012 did not discriminate between genotypes 1a and 1b well enough.
  • When considering Galexos (simeprevir) for treatment, a Q80K resistance test is needed
  • Genotype testing should be done before retreating
BC Centre for Disease Control (BCCDC)

The BC Centre for Disease Control (BCCDC) provides provincial and national leadership in public health through surveillance, detection, treatment, prevention and consultation services. The Centre provides both direct diagnostic and treatment services for people with diseases of public health importance and analytical and policy support to all levels of government and health authorities.

For more information about hep C treatments please visit PHCN’s Hepatitis C Treatment Information Project or email.